http://orcid.org/0000-0003-0013-2460
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Background: Both marijuana use and legalization are increasing, and the cognitive effects of marijuana may play a role in trauma. Our objective was to assess the proportion of patients with a urine drug screen who self-reported use in a population of trauma patients.
Methods: Self-report of marijuana use in trauma patients was recorded for patients with a positive urine toxicology screen at a Level 1 trauma center in Arizona prior to (1/2011 to 4/13/2011) and following (4/14/2011 to 9/2014) legalization of marijuana for medical indications.
Results: Among patients with a positive toxicology screen who were able to report to utilization, 52.5% patients with a positive UDS for marijuana overall reported use. In the pre-legalization group, 59.3% reported use, while in the post-legalization group, 51.4% reported use (p = .188).
Conclusion: Only about half of trauma patients with a positive urine drug screen for marijuana reported use. Self-reporting among UDS-positive patients demonstrated no significant change with the legalization of marijuana for medical reasons.
Disclosure statement
No potential conflict of interest was reported by the author(s).